Pharmaceuticals and Medical Devices: Medicare Part D.
David J
DJ
Steiner
D001741:Black or African American; D000368:Aged; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D059451:Biosimilar Pharmaceuticals; D002317:Cardiovascular Agents; D014487:Centers for Medicare and Medicaid Services, U.S. / Q000331:legislation & jurisprudence; D017046:Cost Savings; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D063026:Dual Medicare Medicaid Eligibility; D017850:Economics, Pharmaceutical / Q000331:legislation & jurisprudence*; D005607:Fraud / Q000331:legislation & jurisprudence; D006801:Humans; D007880:Legislation, Drug / Q000191:economics*; D008484:Medicaid; D020398:Medicare Part C / Q000191:economics / Q000331:legislation & jurisprudence; D054524:Medicare Part D / Q000191:economics* / Q000331:legislation & jurisprudence*; D054539:Medication Therapy Management; D009203:Myocardial Infarction / Q000188:drug therapy; D017063:Outcome Assessment, Health Care; D010594:Pharmacies; D055553:Prescription Drugs / Q000191:economics*; D014481:United States; D014483:United States Dept. of Health and Human Services / Q000331:legislation & jurisprudence
D000701:Analgesics, Opioid; D000928:Antidepressive Agents; D059451:Biosimilar Pharmaceuticals; D002317:Cardiovascular Agents; D055553:Prescription Drugs